Arcangelo Nocera

Summary

Affiliation: San Martino University Hospital
Country: Italy

Publications

  1. ncbi Cytokine mRNA expression in chronically rejected human renal allografts
    Arcangelo Nocera
    Transplant Immunology Unit, San Martino Hospital, Genoa, Italy
    Clin Transplant 18:564-70. 2004
  2. doi Sirolimus therapy in liver transplant patients: an initial experience at a single center
    A Nocera
    Transplant Immunology Unit, San Martino Hospital, Genoa, Italy
    Transplant Proc 40:1950-2. 2008
  3. ncbi [Desensitization protocols in immunized living donor kidney transplant recipients]
    Arcangelo Nocera
    Unita Operativa Semplice Immunologia dei Trapianti, Dipartimento Trapianti, Padiglione XIII II piano, Azienda Ospedaliera Universitaria S Martino, Genova
    G Ital Nefrol 26:499-515. 2009
  4. ncbi Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation
    Sergio Barocci
    Transplant Immunology Unit, Transplantation Department, S Martino Hospital, Genoa, Italy
    Clin Transplant 21:47-56. 2007
  5. ncbi DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant
    Augusto Tagliamacco
    Transplant Immunology Research Laboratory at Clinical Nephrology and Gastroenterology Units, Department of Internal Medicine DIMI, University of Genova, Genova, Italy
    Transpl Int 27:667-73. 2014
  6. ncbi Renal transplantation. Strategies to prevent organ rejection--the role of an inter-regional reference center
    Massimo Cardillo
    Dipartimento Trasfusionale e di Riferimento per il Trapianto di Organi e Tessuti, RCCS Ospedale Maggiore Policlinico, Milano, Italy
    Contrib Nephrol 146:1-10. 2005
  7. ncbi Successful double bone marrow and renal transplantation in a patient with Fanconi anemia
    Maurizio Miano
    Blood 99:3482-3. 2002
  8. ncbi Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients
    Patrizia Comoli
    Laboratory of Transplant Immunology and Pediatric Hematology Oncology, IRCCS Policlinico S Matteo, Pavia, Italy
    J Am Soc Nephrol 14:3197-204. 2003
  9. ncbi Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells
    Patrizia Comoli
    Laboratory of Transplant Immunology and Pediatric Hematology Oncology, IRCCS Policlinico S Matteo, Pavia, Italy
    Am J Transplant 5:1415-22. 2005

Collaborators

Detail Information

Publications9

  1. ncbi Cytokine mRNA expression in chronically rejected human renal allografts
    Arcangelo Nocera
    Transplant Immunology Unit, San Martino Hospital, Genoa, Italy
    Clin Transplant 18:564-70. 2004
    ..Moreover, IL-10 seems to exquisitely characterize a group of CR/CAN kidney grafts more prone to immunologic assaults...
  2. doi Sirolimus therapy in liver transplant patients: an initial experience at a single center
    A Nocera
    Transplant Immunology Unit, San Martino Hospital, Genoa, Italy
    Transplant Proc 40:1950-2. 2008
    ..In conclusion, SRL appeared to be an effective immunosuppressant that could be used as monotherapy in liver transplant patients. Any conclusion on SRL anticancer effects can only come from randomized large studies after long follow-up...
  3. ncbi [Desensitization protocols in immunized living donor kidney transplant recipients]
    Arcangelo Nocera
    Unita Operativa Semplice Immunologia dei Trapianti, Dipartimento Trapianti, Padiglione XIII II piano, Azienda Ospedaliera Universitaria S Martino, Genova
    G Ital Nefrol 26:499-515. 2009
    ....
  4. ncbi Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation
    Sergio Barocci
    Transplant Immunology Unit, Transplantation Department, S Martino Hospital, Genoa, Italy
    Clin Transplant 21:47-56. 2007
    ..2% for class II). These findings may have important implications to improve donor-recipient matching in dialysis recipients waiting for a subsequent renal transplantation...
  5. ncbi DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant
    Augusto Tagliamacco
    Transplant Immunology Research Laboratory at Clinical Nephrology and Gastroenterology Units, Department of Internal Medicine DIMI, University of Genova, Genova, Italy
    Transpl Int 27:667-73. 2014
    ..Our results indicate a need for evaluating HLA-DQ compatibilities in kidney allocation, in order to minimize post-transplant development of de novo DSA, known to be responsible for antibody-mediated rejection and graft loss. ..
  6. ncbi Renal transplantation. Strategies to prevent organ rejection--the role of an inter-regional reference center
    Massimo Cardillo
    Dipartimento Trasfusionale e di Riferimento per il Trapianto di Organi e Tessuti, RCCS Ospedale Maggiore Policlinico, Milano, Italy
    Contrib Nephrol 146:1-10. 2005
    ....
  7. ncbi Successful double bone marrow and renal transplantation in a patient with Fanconi anemia
    Maurizio Miano
    Blood 99:3482-3. 2002
  8. ncbi Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients
    Patrizia Comoli
    Laboratory of Transplant Immunology and Pediatric Hematology Oncology, IRCCS Policlinico S Matteo, Pavia, Italy
    J Am Soc Nephrol 14:3197-204. 2003
    ..Application of this culture system may allow a preemptive therapy approach to BKV-related complications in transplant recipients, based on CTL treatment guided by BKV DNA levels...
  9. ncbi Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells
    Patrizia Comoli
    Laboratory of Transplant Immunology and Pediatric Hematology Oncology, IRCCS Policlinico S Matteo, Pavia, Italy
    Am J Transplant 5:1415-22. 2005
    ..These preliminary results suggest that a combined chemoimmunotherapy regimen including virus-specific T-cells is well tolerated and potentially effective as first-line treatment of EBV-related PTLD...